C5 Inhibition in Secondary Thrombotic Microangiopathies: A Yet Unresolved Question. [PDF]
Werion A, Rondeau E.
europepmc +1 more source
Emerging Novel Etiology for Thrombotic Microangiopathies: COVID-19 Infection
Kübra Kaynar +4 more
doaj +1 more source
Complement activation in secondary thrombotic microangiopathies. [PDF]
Morelle J +14 more
europepmc +1 more source
Ocular manifestations of primary thrombotic microangiopathies : a descriptive systematic review. [PDF]
Baker M +8 more
europepmc +1 more source
Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis-Induced Thrombotic Microangiopathies. [PDF]
Gouin A +10 more
europepmc +1 more source
Pathogenic cytokines in thrombotic microangiopathies: molecular insights and therapeutic targets. [PDF]
Obeagu EI.
europepmc +1 more source
Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis. [PDF]
Burguet L +10 more
europepmc +1 more source
Dynamic Monitoring of ADAMTS-13 Activity for Differential Diagnosis Across the Spectrum of Sepsis-Associated Thrombotic Microangiopathies. [PDF]
Liu Y +6 more
europepmc +1 more source
Thrombotic microangiopathies: First report of 294 cases from a single institution experience in Argentina. [PDF]
Dos Santos C +8 more
europepmc +1 more source
Complement-Mediated Thrombotic Microangiopathies With Predominant Renal Involvement in a Patient With Lupus Nephritis. [PDF]
Manchikalapati A +2 more
europepmc +1 more source

